Zobrazeno 1 - 10
of 37
pro vyhledávání: '"J. Duplisea"'
Autor:
Alexis R. Steinmetz, Morgan Pierce, Alberto Martini, Come Tholomier, Ganiraju Manyam, Yan Chen, Akshay Sood, Jonathan J. Duplisea, Burles A. Johnson, Bogdan A. Czerniak, Byron H. Lee, Chinnaswamy Jagannath, Seppo Yla-Herttuala, Nigel R. Parker, David J. McConkey, Colin P. Dinney, Sharada Mokkapati
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionNadofaragene firadenovec (Ad-IFNα/Syn3) is now approved for BCG-unresponsive bladder cancer (BLCA). IFNα is a pleiotropic cytokine that causes direct tumor cell killing via TRAIL-mediated apoptosis, angiogenesis inhibition, and activati
Externí odkaz:
https://doaj.org/article/63a622d2fe494a5898ec7dc003c1d01b
Autor:
Sharada Mokkapati, Vikram M. Narayan, Ganiraju C. Manyam, Amy H. Lim, Jonathan J. Duplisea, Andrea Kokorovic, Tanner S. Miest, Anirban P. Mitra, Devin Plote, Selvalakshmi Selvaraj Anand, Michael J. Metcalfe, Kenneth Dunner, Jr., Burles A. Johnson, Bogdan A. Czerniak, Tiina Nieminen, Tommi Heikura, Seppo Yla-Herttuala, Nigel R. Parker, Kimberley S. Schluns, David J. McConkey, Colin P. Dinney
Publikováno v:
Molecular Therapy: Oncolytics, Vol 26, Iss , Pp 141-157 (2022)
Interferon alpha (IFNα) gene therapy is emerging as a new treatment option for patients with non-muscle invasive bladder cancer (NMIBC). Adenoviral vectors expressing IFNα have shown clinical efficacy treating bacillus Calmette-Guerin (BCG)-unrespo
Externí odkaz:
https://doaj.org/article/5de742af926648bcab7840c44c6fac3e
Publikováno v:
Burns Open, Vol 6, Iss 3, Pp 110-115 (2022)
Stevens-Johnson syndrome (SJS), toxic-epidermal necrolysis (TEN), and SJS-TEN overlap syndrome form a continuum of rare, life-threatening disease that often warrants immediate and intensive treatment in a burn center. Our objective in this study was
Externí odkaz:
https://doaj.org/article/595a41f37a444a40bb1228be9beb90e3
Autor:
Hui Yao, Li Zhang, Colin Dinney, John N. Weinstein, Vipulkumar Dadhania, Jonathan J. Duplisea, Miao Zhang, Bogdan Czerniak, Keith A. Baggerly, David J. McConkey, Sangkyou Lee, Charles C. Guo, Ashish M. Kamat, Ziqiao Wang, Peng Wei, Shizhen Zhang, Tadeusz Majewski, He Huang, H. Barton Grossman, Yan Wang, James E. Ferguson, David Cogdell, Jolanta Bondaruk, June Goo Lee, Jianjun Gao
Publikováno v:
Cell Reports, Vol 27, Iss 6, Pp 1781-1793.e4 (2019)
Summary: Sarcomatoid urothelial bladder cancer (SARC) displays a high propensity for distant metastasis and is associated with short survival. We report a comprehensive genomic analysis of 28 cases of SARC and 84 cases of conventional urothelial carc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5975750f0fd5bb495cff9bf1fbfcacc
http://www.sciencedirect.com/science/article/pii/S2211124719305212
http://www.sciencedirect.com/science/article/pii/S2211124719305212
Autor:
David J. McConkey, Jonathan J. Duplisea, Vikram M. Narayan, Tommi Heikura, Michael Metcalfe, Devin Plote, Amy Lim, Sharada Mokkapati, Nigel Parker, Tiina Nieminen, Yla-Herttuala Seppo, Colin P.N. Dinney, Andrea Kokorovic
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Previous studies have demonstrated efficacy of intravesical delivery of interferon-α (IFNα) using an adenoviral vector for the treatment of bacillus-calmette guerin (BCG)...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64cafe4432c43d0ddf7d8f7899bb765d
https://doi.org/10.1097/ju.0000000000000922.08
https://doi.org/10.1097/ju.0000000000000922.08
Autor:
Kimberly S. Schluns, Nigel Parker, Seppo Ylä-Herttuala, Devin Plote, Colin P.N. Dinney, David J. McConkey, Jonathan J. Duplisea, Sharada Mokkapati
Publikováno v:
World J Urol
BCG unresponsive bladder cancer is an inherently resistant disease state for which the preferred treatment is radical cystectomy. To date, no effective intravesical therapies exist for patients who possess these resistant tumors. For this reason, man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2456970e0fe132a135f0eff681057c9
https://doi.org/10.1007/s00345-018-2553-7
https://doi.org/10.1007/s00345-018-2553-7
Publikováno v:
Expert Review of Anticancer Therapy. 19:543-545
Platinum-based chemotherapy has served as the mainstay systemic treatment for muscle invasive bladder cancer (MIBC) for decades. Its use in the neoadjuvant (NAC), adjuvant (AC), and salvage setting...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4764adb83d8f9dc666dffe46d5006a78
https://doi.org/10.1080/14737140.2019.1625773
https://doi.org/10.1080/14737140.2019.1625773
Autor:
Bogdan Czerniak, John C. Araujo, Charles C. Guo, Jonathan J. Duplisea, Arlene O. Siefker-Radtke, Surena F. Matin, Colin P.N. Dinney, Firas G. Petros, Roger Li, Bryan Fellman
Publikováno v:
Urol Oncol
Purpose Micropapillary variant upper tract urothelial cancer (MP-UTUC) is a rare malignancy with little known regarding its clinical course and/or optimal treatment. In this case series, we describe patient characteristics, surgical treatment, oncolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4d4e365e5c6007d4e12b2ed285b4bde
https://europepmc.org/articles/PMC6511295/
https://europepmc.org/articles/PMC6511295/
Autor:
Stephen A. Boorjian, Roger Li, Ross J. Mason, Colin P.N. Dinney, Chad A. Reichard, Yu Shen, Jonathan J. Duplisea
Introduction: Neoadjuvant chemotherapy (NAC) prior to radical or partial cystectomy is considered the standard of care for eligible patients with muscle-invasive urothelial carcinoma. Despite guideline recommendations, adoption of NAC has historicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0802ca1b6efe08363937b2930bed9d
https://europepmc.org/articles/PMC6363565/
https://europepmc.org/articles/PMC6363565/
Autor:
Curtis A. Pettaway, Barrett McCormick, John Papadopoulos, Mehrad Adibi, Pheroze Tamboli, Priya Rao, Wei Qiao, Andrea Kokorovic, Jonathan J. Duplisea, Gabriela Ramirez
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 39:302.e19-302.e27
Objectives To determine the oncologic outcomes of organ sparing surgery (OSS) for penile cancer and to determine the management of and risk factors for local recurrence at a tertiary referral center in the United States. Methods and Materials Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c4dce7ac7fd762d2c41c15935e8496e
https://doi.org/10.1016/j.urolonc.2021.02.004
https://doi.org/10.1016/j.urolonc.2021.02.004